ANI Pharmaceuticals | ANIP - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
ANI Pharmaceuticals USD 73.83M 4.14M 2026-06
Aurora Cannabis CAD 9.31M 58.72M 2026-03
Canopy Growth CAD 34.82M 14.85M 2026-03
Eli Lilly USD 6.11B 1.08B 2026-06
Emergent BioSolutions USD 112.2M 500K 2023-12
Heron Therapeutics USD 11.64M 2.67M 2026-06
Hikma Pharmaceutical USD 715M 104M 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Nektar Therapeutics USD 10.03M 744K 2026-03
Novartis USD 4.32B 134M 2026-03
Omeros USD 8.84M 4.42M 2025-06
Perrigo USD 400.4M 34.4M 2026-06
Sun Pharmaceuticals INR 73.34B 6.28B 2026-03
Teva Pharmaceutical Industries USD 2.72B 125M 2026-06